心脉通胶囊对冠心病患者血管调节肽的影响  

Influence of Xinmaitong Capsule on Adjusting Peptides of Blood Vessels in Cases of Coronaray Heart Disease

作　　者：丘瑞香[1] 贺敬波[2] 

机构地区：[1]中山医科大学附属第一医院,广州市中山二路58号510080 [2]深圳市宝安区人民医院

出　　处：《中医杂志》1998年第5期281-282,共2页Journal of Traditional Chinese Medicine

基　　金：广东省中医管理局资助课题(No.94081)

摘　　要：为探讨心脉通胶囊对冠心病心肌缺血患者的治疗作用,40例冠心病心肌缺血患者在常规西药治疗基础上随机分组。结果:两组患者ET明显高于健康人(P<0.001),CGRP变化不明显(P>0.05)。治疗后两组患者ET及症状计分明显降低(P<0.01),ST段明显升高(P<0.01),但心脉通组ET、症状计分降低及ST段上升幅度明显大于对照组(P<0.05～0.01);常规用药者CGRP变化不明显(P>0.05),加用心脉通胶囊者CGRP明显提高(P<0.01)。Forty cases of CHD with myocardial ischemia treated conventionally with western drugs were divided into groups randomly to probe into the action of Xinmaitong Capsule on myocardial ischemia. Results revealed that the ET in both groups was higher than normal person (P<0. 001): while no obvious changes, on CGRP can be observed. (P > 0. 05). After treatment. ET and scoring of symptoms were markedly lowered (P<0. 01), ST segment markedly elevated (P<0. 01). However, ET, symptom scoring and amplitude of ST elevation in Xinmaitong group were all higher than the control group (P<0. 05 -0. 01 ). For cases of conventional drug therapy, changes of CGRP was not conspicuous, while that of the Xinmaitong group was obviously elevated (P < 0. 01).

关 键 词：中医药疗法 内皮缩血管肽 心脉通胶囊 冠心病 

分 类 号：R259.414[医药卫生—中西医结合]